4 Nuvama ‘Buy’ recommendations: Why Lupin, Biocon, Torrent Pharma and IPCA Labs offer up to 27% upside
- Posted on February 19, 2026
- By Financial Express
- 2 Views
4 Nuvama ‘Buy’ recommendations: Why Lupin, Biocon, Torrent Pharma and IPCA Labs offer up to 27% upside
Nuvama has flagged four pharma stocks as top ‘Buy’ picks, citing strong US launches, biosimilars traction and margin expansion with potential upside of up to 27% over the next year.
